TrialHuman molecular genetics2014

Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).

Brett Tortelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.